SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-220549
Filing Date
2022-08-15
Accepted
2022-08-15 07:12:32
Documents
18
Period of Report
2022-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d291170d8k.htm   iXBRL 8-K 34192
2 EX-10.1 d291170dex101.htm EX-10.1 126239
3 EX-99.1 d291170dex991.htm EX-99.1 92357
7 GRAPHIC g291170g21a40.jpg GRAPHIC 7431
8 GRAPHIC g291170g74p47.jpg GRAPHIC 7556
9 GRAPHIC g291170g86a14.jpg GRAPHIC 7475
10 GRAPHIC g291170g90l93.jpg GRAPHIC 8287
  Complete submission text file 0001193125-22-220549.txt   467695

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atai-20220815.xsd EX-101.SCH 2836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20220815_lab.xml EX-101.LAB 18670
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20220815_pre.xml EX-101.PRE 11670
12 EXTRACTED XBRL INSTANCE DOCUMENT d291170d8k_htm.xml XML 3580
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 221162295
SIC: 2834 Pharmaceutical Preparations